Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Deconstruction of an African folk medicine uncovers a novel molecular strategy for therapeutic potassium channel activation.

De Silva AM, Manville RW, Abbott GW.

Sci Adv. 2018 Nov 14;4(11):eaav0824. doi: 10.1126/sciadv.aav0824. eCollection 2018 Nov.

2.

Ancient and modern anticonvulsants act synergistically in a KCNQ potassium channel binding pocket.

Manville RW, Abbott GW.

Nat Commun. 2018 Sep 21;9(1):3845. doi: 10.1038/s41467-018-06339-2.

3.

Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels.

Manville RW, Abbott GW.

Mol Pharmacol. 2018 Oct;94(4):1155-1163. doi: 10.1124/mol.118.112953. Epub 2018 Jul 18.

PMID:
30021858
4.

Direct neurotransmitter activation of voltage-gated potassium channels.

Manville RW, Papanikolaou M, Abbott GW.

Nat Commun. 2018 May 10;9(1):1847. doi: 10.1038/s41467-018-04266-w.

5.

SMIT1 Modifies KCNQ Channel Function and Pharmacology by Physical Interaction with the Pore.

Manville RW, Neverisky DL, Abbott GW.

Biophys J. 2017 Aug 8;113(3):613-626. doi: 10.1016/j.bpj.2017.06.055.

Supplemental Content

Loading ...
Support Center